Explore 3 Stock Ideas & Industry Insights Download Free Report
Ormat Technologies, Inc.

ORA Details
Ormat Technologies, Inc. (NYSE: ORA) happens to be a leading renewable energy provider.

Results Highlights for the Period Ended 30 June 2021 (Q2FY21)

Key Data (Source: Company Reports)
Recent Update
Outlook
The company has guided the revenue in the range of $650-$685 million in FY21 and adjusted EBITDA to stay in the range of $400-$410 million in FY21. For FY 2021, electricity segment revenues is expected in the range of $585 Mn-$595 Mn and product segment revenues is expected in the range of $40 million and $60 million. Besides, the company is going as per the plan of increasing its combined geothermal, energy storage, and solar generating portfolio to more than 1.5 GW by 2023.
Key Risks
The company’s global operations are exposed to risks like foreign laws and regulations along with geopolitical risk and acts of terrorism. Besides, a sustained drop in products backlog could have an adverse bearing on its target of full utilization of the production and manufacturing facilities.
Valuation Methodology: EV/Sales Based Relative Valuation (Illustrative)

Technical Overview:
Chart:

Source: REFINITIV
Note: Orange Color Line Reflects RSI (14-Period)

Stock Recommendation
The company’s current ratio for Q2FY21 stood at 2.39x, better than the industry median of 1.02x, implying that the company possesses better capabilities to meet its short-term obligations than its peer group. Its Debt-to-Equity ratio for Q2FY21 stood at 0.78x, lower than the industry median of 2.43x, depicting reasonable leverage position of the company.
The stock has been valued using EV/Sales multiple-based illustrative relative valuation method and the target price so arrived reflects a rise of low double-digit (in % terms). A slight premium has been applied to EV/Sales Multiple (NTM) (Peer Average) considering higher revenues from electricity in 2Q FY 2021 on the YoY basis as well as decent outlook.
Considering the aforementioned factors, we give a “Buy” recommendation on the stock at the current market price of $70.10 per share, down by 2.04% as on 25th October 2021.
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!